Dr. Byrne's interests include clinico-pathologic investigation of malignant lymphoma, Hodgkin’s lymphoma and leukemic processes. Recent focus has been the application of new molecular diagnostic techniques to the diagnosis and subcategorization of hematologic malignancies.